Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy

Table 2

Potential small molecular drugs based on ICI scores through the CMap database.

Rank		CMap name	Mean	n	Enrichment		Specificity	Percent nonnull
1		Carbarsone	0.345	4	0.863	0.00048	0	50
2		Sulfabenzamide	0.312	4	0.8	0.00302	0.0072	50
3		Phenazone	−0.359	3	−0.838	0.00853	0.0173	66
4		Prestwick-675	−0.468	4	−0.743	0.00869	0.0928	75
5		Epitiostanol	−0.386	4	−0.712	0.0141	0.0432	50
6		Cinoxacin	−0.5	4	−0.701	0.01675	0.0197	75
7		Econazole	0.508	4	0.7	0.01677	0.1282	75
8		Betulin	0.456	3	0.771	0.02396	0.0127	66
9		Mevalolactone	−0.443	3	−0.77	0.02504	0.0514	66
10		Depudecin	0.391	2	0.887	0.0263	0.0188	50
11	Antazoline		−0.433	4	−0.658	0.03127	0.0315	75
12	16,16-Dimethylprostaglandin E2		−0.388	3	−0.749	0.03219	0.0276	66
13	Naftidrofuryl		−0.3	4	−0.653	0.03428	0.0065	50
14	Metixene		−0.273	4	−0.65	0.03555	0.0615	50
15	Zidovudine		0.281	4	0.644	0.03873	0.0245	50
16	Metergoline		0.336	4	0.638	0.04205	0.1726	50
17	Harmaline		−0.268	4	−0.636	0.04255	0.0353	50